SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-036780
Filing Date
2023-08-02
Accepted
2023-08-02 07:48:27
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-20230630.htm   iXBRL 10-Q 3443773
2 EX-3.1 kpti-ex3_1.htm EX-3.1 126922
3 EX-4.1 kpti-ex4_1.htm EX-4.1 174535
4 EX-10.4 kpti-ex10_4.htm EX-10.4 250790
5 EX-10.5 kpti-ex10_5.htm EX-10.5 131124
6 EX-31.1 kpti-ex31_1.htm EX-31.1 14168
7 EX-31.2 kpti-ex31_2.htm EX-31.2 14204
8 EX-32.1 kpti-ex32_1.htm EX-32.1 8734
9 EX-32.2 kpti-ex32_2.htm EX-32.2 9032
  Complete submission text file 0000950170-23-036780.txt   10712026

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kpti-20230630_cal.xml EX-101.CAL 46781
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kpti-20230630_lab.xml EX-101.LAB 408677
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20230630_def.xml EX-101.DEF 206645
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20230630.xsd EX-101.SCH 49170
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20230630_pre.xml EX-101.PRE 311173
61 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20230630_htm.xml XML 1766776
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 231133750
SIC: 2834 Pharmaceutical Preparations